Posts Tagged ‘treatment’
The 9 Truths About Hepatitis C Treatment Success
As the medications for Hepatitis C continue to improve, greater numbers of people are relishing in their successful treatment outcomes. Despite finally being free of the Hepatitis C virus, most physicians refrain from telling their patients they are cured. The reason for avoiding this terminology is uncertainty regarding the implications of successful Hepatitis C treatment.…
Read MoreWho Is Getting Hep C Treatment?
The Hepatitis C virus causes progressive liver damage and is the leading cause of liver transplants in the U.S., yet its gravity is frequently disregarded. According to the U.S. Centers for Disease Control and Prevention, more people die from Hepatitis C than from 60 other infectious diseases combined. Despite major advances in Hepatitis C treatment,…
Read MoreNCKU team discovers new liver disease treatment
NCKU team discovers new liver disease treatment TAIPEI, Taiwan — A National Cheng Kung University (NCKU) team has discovered the pathogenesis of liver fibrosis and developed antibodies that reduce liver damage, inhibit hepatic fibrosis and recover liver function, according to a press release from the school. Ming-shi Chang, chair professor of biochemistry and molecular biology…
Read MoreThe cure for hepatitis C is upon us
The cure for hepatitis C is upon us, but at a costly penny ANDRÉ PICARD (Corrected version) The Globe and Mail Published Sunday, Apr. 27 2014, 4:00 PM EDT Last updated Sunday, Apr. 27 2014, 10:33 PM EDT There is a revolution coming to the treatment of hepatitis C. But a big fat asterisk is…
Read MoreNew Drug Combo Cures Toughest Cases of Hepatitis C, Hints to Future Injection-Free Therapies
Hints to Future Injection-Free Therapies 5 hours ago0 Comments Posted in News, Hepatitis, Research Efforts to cure hepatitis C, the liver-damaging infectious disease that has for years killed more Americans than HIV/AIDS, are about to get simpler and more effective, according to new research at Johns Hopkins and elsewhere. In a study to be…
Read MoreFDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection
FDA approves OLYSIO (simeprevir) Janssen Therapeutics, Division of Janssen Products, LP (Janssen), announced today the U.S. Food and Drug Administration (FDA) has approved OLYSIO™ (simeprevir), an NS3/4A protease inhibitor, for the treatment of chronic hepatitis C infection as part of an antiviral treatment regimen in combination with pegylated interferon and ribavirin in genotype 1 infected…
Read MoreFDA approves new treatment for hepatitis C virus
FDA approves new treatment for hepatitis C virus FDA NEWS RELEASE For Immediate Release: Nov. 22, 2013 Media Inquiries: Stephanie Yao, 301-796-0394, stephanie.yao@fda.hhs.gov Consumer Inquiries: 888-INFO-FDA FDA approves new treatment for hepatitis C virus The U.S. Food and Drug Administration today approved Olysio (simeprevir), a new therapy to treat chronic hepatitis C virus infection. Hepatitis…
Read MoreSofosbuvir taken before or after liver transplant reduces hepatitis C recurrence
Sofosbuvir taken before or after liver transplant reduces hepatitis C recurrence Liz Highleyman An interferon-free combination of sofosbuvir plus ribavirin administered before liver transplantation prevented hepatitis C recurrence in nearly two-thirds of patients, while the same regimen led to early viral clearance in three-quarters of those treated after transplantation, according to studies presented this week…
Read MoreAlcohol abuse treatment programs helped liver transplant patients before and after surgery
Alcohol abuse treatment programs October 7, 2013 Liver transplant patients with a history of alcohol abuse often go through a treatment program before surgery. But the temptation to drink doesn’t stop once the surgery is over. A recent study looked at a group of liver transplant patients to see who returned to drinking after surgery.…
Read MoreCuring Hepatitis C
Curing Hepatitis C BALTIMORE, Md. (Ivanhoe Newswire) — Hepatitis C is the most common bloodborne viral infection in the US, affecting more than 4-million people. The deadly disease can lead to cirrhosis of the liver and liver cancer. Now there is a new era of hepatitis-c drugs that could cure the disease, without side effects.…
Read More